Physician profile
David Litoff
NPI 1720165939
$6,266.36
in general payments reported to CMS, 2019-2025
24 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 78% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $406 · 2021: $345 · 2022: $889 · 2023: $1,091 · 2024: $1,822 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,873 · Entertainment: $88.18.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,873.42 |
| Entertainment | $88.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,859.62 | 2019-2025 | Clareon, Wavelight Refractive Suite, Argos |
| Rxsight INC | $949.82 | 2021-2024 | Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece |
| Biotissue Holdings INC. | $563.15 | 2022-2025 | |
| Glaukos Corporation | $549.52 | 2023-2025 | Idosetr, Istent Trabecular Micro-Bypass System Model Is3 |
| Bausch & Lomb Americas INC. | $211.44 | 2023-2025 | Scoutpro Osmolarity System, Miebo, Infuse |
| Johnson & Johnson Surgical Vision, INC. | $205.85 | 2022-2024 | Tecnis Simplicity |
| Novartis Pharmaceuticals Corporation | $177.86 | 2020-2023 | |
| Dompe US, INC. | $114.01 | 2025 | Oxervate |
| Sun Pharmaceutical Industries INC. | $108.14 | 2024-2025 | |
| Abbvie INC. | $104.98 | 2023-2025 | |
| Optos, INC. | $88.18 | 2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Mallinckrodt Hospital Products INC. | $49.35 | 2022 | |
| Carl Zeiss Meditec, INC. | $47.57 | 2019 | |
| Harrow Eye, LLC | $43.29 | 2024-2025 | Vevye |
| Quidel Corporation | $32.24 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tearlab Corp | $30.86 | 2022 | |
| Thea Pharma INC. | $21.51 | 2024 | Iyuzeh |
| Aerie Pharmaceuticals, INC. | $19.64 | 2019 | |
| Ocular Therapeutix, INC. | $16.43 | 2021 | |
| Staar Surgical Company | $15.97 | 2019 | |
| Horizon Therapeutics Plc | $14.87 | 2020 | |
| Oyster Point Pharma, INC. | $14.58 | 2023 | Tyrvaya |
| Allergan, INC. | $14.01 | 2021 | |
| Rayner Intraocular Lenses Limited | $13.47 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Litoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.